Lucy Mangan

Losing significant weight on semaglutide brings personal relief from long‑standing body image struggles, but the growing popularity of GLP‑1 drugs risks deepening societal harm. Weight loss remains tied to cultural pressures that reward thinness, with new medications reinforcing discrimination and masking the underlying misogyny that shapes expectations of women’s bodies. The drugs may improve individual lives yet worsen the social forces that drive women toward conformity rather than self‑acceptance.